Solid phase synthesis of anthraquinone peptides and their evaluation as topoisomerase I inhibitors.
Anthraquinone peptide derivatives have previously been shown to inhibit the enzyme topoisomerase I (topo I), a pharmaceutical target for the prevention of malignant carcinomas. A highly efficient procedure for the attachment of the anthraquinone moiety to the N-terminus of a peptide on a solid support is reported. This methodology provides a convenient method for the synthesis of labelled peptides, with potential applications for chemotherapy, DNA detection and protein purification. As the synthetic strategy utilizes the solid phase, it should also be amenable to the generation of combinatorial libraries. The utility of the method by synthesizing a pool of peptides and assaying for topo I inhibition is demonstrated.
Giles
Gregory I
GI
Division of Biochemistry and Molecular Biology, School of Biological Sciences, Bassett Crescent East, University of Southampton, SO16 7PX, UK.
Sharma
Ram P
RP
D000873:Anthracenes / Q000378:metabolism; D000880:Anthraquinones / Q000138:chemical synthesis* / Q000494:pharmacology*; D002166:Camptothecin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods; D010455:Peptides / Q000138:chemical synthesis* / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D059004:Topoisomerase I Inhibitors
D000873:Anthracenes; D000880:Anthraquinones; D010455:Peptides; D059004:Topoisomerase I Inhibitors; C049364:leucoquinizarin; D002166:Camptothecin